WST US EQUITY Health Care Health Care Supplies CIK: 105770

West Pharmaceutical Services (WST) Quant Factor Diagnostic & Fair Value Model

West Pharmaceutical Services (Ticker: WST) is listed in the Health Care sector (Health Care Supplies). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.

$392.15

-0.48% Latest Close (2026-10-23)

Market Cap: $21.34M

P/E Ratio: 45.6

Momentum Strength 3M / 12M

+18.38%

1M: +4.97% 12M: +41.57%

Quality (ROE) Point-in-Time

+20.60%

Trailing Return on Equity

Technical Trend RSI 14

66.6

SMA50: $362.07 SMA200: $310.10

Valuation Multiplier Trailing

45.6

Premium Multiple (> 30x P/E)

📊 Valuation & Multi-Factor Diagnostic

Premium Multiple (> 30x P/E)

WST trades at 45.6x P/E, reflecting market-implied growth expectations for forward revenue and cash flow.

Compare in Screener

⚡ Benchmark Factor Strategy

S&P 500 Momentum Alpha Strategy

This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.

Strategy Marketplace Open Strategy →

📈 Daily Candlestick & Volume Quant Chart

Interactive lightweight price action & volume breakdown over recent 90 trading days.

均线多头 (MA20/50) Piotroski F-Score: 6/9 (Moderate Financial Health)

Official Point-in-Time Financial Filing History

Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.

备案 CIK: 105770 · 10-K 年报 / 10-Q 季报

Form	Period End	Filing Timestamp (Point-in-Time)	Revenue	Net Income	Operating CF	EPS (Diluted)
10-Q	2026-06-30	2026-07-23	-	$154.00M	$213.90M	$2.15
10-Q	2026-03-31	2026-07-23	-	$138.80M	$89.90M	$1.92
10-Q	2025-12-31	2026-07-23	-	-	-	-
10-Q	2025-06-30	2026-07-23	-	$131.80M	$306.50M	$1.82
10-Q	2025-03-31	2026-07-23	-	$89.80M	$129.40M	$1.23
10-K	2025-12-31	2026-02-17	-	$493.70M	$754.80M	$6.79
10-K	2024-12-31	2026-02-17	-	$492.70M	$653.40M	$6.69
10-K	2023-12-31	2026-02-17	-	$593.40M	$776.50M	$7.88

💡 Methodology & Frequently Asked Questions

Key reference details regarding West Pharmaceutical Services (WST) valuation multiples, momentum factors, and point-in-time filing conventions.

How should WST's current valuation multiple be interpreted? ↓

WST trades at a trailing P/E of 45.6x within the Health Care sector (premium multiple (> 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.

What are WST's key momentum and technical factor indicators? ↓

As of the latest close, WST shows a 1-month return of +4.97%, 3-month return of +18.38%, and 12-month return of +41.57%, with a 14-day RSI of 66.6. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.

What is Point-in-Time (PIT) financial data and why does it matter for WST? ↓

Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.

How can WST be incorporated into systematic factor models? ↓

WST can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.